Related Experiment Video
Updated: May 30, 2025

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
Effect of taurine supplementation on preventing ventilator-associated pneumonia in pediatrics under mechanical
Nasrin Shirzad-Yazdi1,2, Eslam Shorafa3, Seyedeh Narjes Abootalebi3,4
1Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
Insights
Taurine supplementation significantly reduced ventilator-associated pneumonia (VAP) incidence in pediatric intensive care units. This treatment also shortened mechanical ventilation duration and hospital stays for critically ill children.
Area of Science:
- Critical Care Medicine
- Pediatric Infectious Diseases
- Nutritional Science
Background:
- Ventilator-associated pneumonia (VAP) is a common and costly healthcare-associated infection in pediatric intensive care units (PICUs).
- VAP leads to extended hospital stays, increased healthcare costs, and significant patient morbidity.
- Preventive strategies for VAP are crucial for improving outcomes in critically ill children.
Purpose of the Study:
- To evaluate the efficacy of taurine supplementation in preventing ventilator-associated pneumonia (VAP) in pediatric intensive care unit (PICU) patients.
- To assess the impact of taurine on the duration of mechanical ventilation, ICU stay, and hospital stay.
- To investigate the effect of taurine on inflammatory markers in critically ill pediatric patients.
Main Methods:
- A double-blind, randomized clinical trial involving pediatric patients requiring mechanical ventilation for over 48 hours.
- Patients were randomized to receive either taurine (30 mg/kg/day) or a placebo, in addition to standard care.
- The primary outcome was the incidence of VAP, assessed through clinical and laboratory evidence.
Main Results:
- VAP incidence was substantially lower in the taurine group (7.9%) compared to the placebo group (64.1%).
- Taurine supplementation significantly reduced mechanical ventilation duration, ICU stay, and hospital stay.
- Taurine treatment also led to a decrease in inflammatory markers, including CRP, pro-calcitonin, and interleukin-6.
Conclusions:
- Taurine supplementation is an effective strategy for reducing VAP incidence in critically ill pediatric patients.
- Taurine administration can shorten the duration of mechanical ventilation and intensive care unit (ICU) and hospital stays.
- The findings suggest taurine has lung-protective properties beneficial in the PICU setting.
Introduction:
One of the most prevalent healthcare-associated infections in the pediatric intensive care unit is ventilator-associated pneumonia (VAP). VAP not only results in prolonged hospital and intensive care unit (ICU) stays but also imposes higher costs on patients and the healthcare system. Therefore, it is essential to implement preventive measures. The lung-protective properties of taurine are recognized, and this research focuses on assessing the impact of taurine supplementation in preventing VAP.
Method:
This double-blind, randomized clinical trial was conducted at Namazi Hospital's PICUs. The study included pediatrics on mechanical ventilation for over 48 h. Patients were randomly divided into two groups: the taurine and placebo groups. Alongside the standard care, participants from both groups were administered taurine or placebo capsules (30 mg/kg. day) in divided doses from the day of PICU admission through PICU discharge. The incidence of VAP through clinical and laboratory evidence was considered the primary outcome.
Results:
Seventy-seven patients were included in the study, with 38 in the taurine group and 39 in the placebo group. VAP incidence was 7.9% in the taurine group and 64.1% in the placebo group. Taurine significantly reduced the duration of mechanical ventilation, ICU and hospital stay, and inotrope duration. The occurrence of septic shock was lower in the taurine group at 5.3%. Stepwise logistic regression showed that placebo receipt was the only risk factor for VAP, with placebo recipients being 20.8 times more likely to develop VAP. (P < 0.0001, OR 20.8, 95% CI 6.11-97.93) Taurine treatment also significantly reduced inflammatory markers such as CRP, pro-calcitonin, and interleukin-6 compared to placebo.
Conclusion:
Our results showed that taurine supplementation can reduce the incidence of VAP and the duration of mechanical ventilation, ICU, and hospital stay in critically ill pediatric patients.
Registration Number Of The Clinical Trial:
This study received approval from the Iranian registry clinical trial, registered on 29 June 2023 (IRCT20120731010453N4, http://www.irct.ir/).
More Related Videos
06:22Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS
Published on: April 7, 2021
05:36Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine
Published on: January 30, 2020
Related Concept Videos
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Mechanical Ventilation II: Invasive Ventilation
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Mechanical Ventilation I: Indication and Settings
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation...
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...